GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » Price-to-Owner-Earnings

Hyphens Pharma International (SGX:1J5) Price-to-Owner-Earnings : 5.90 (As of May. 22, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International Price-to-Owner-Earnings?

As of today (2024-05-22), Hyphens Pharma International's share price is S$0.295. Hyphens Pharma International's Owner Earnings per Share (TTM) ended in Dec. 2022 was S$0.05. It's Price-to-Owner-Earnings for today is 5.90.


The historical rank and industry rank for Hyphens Pharma International's Price-to-Owner-Earnings or its related term are showing as below:

SGX:1J5' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.52   Med: 15   Max: 33.18
Current: 6.15

During the past 8 years, the highest Price-to-Owner-Earnings of Hyphens Pharma International was 33.18. The lowest was 5.52. And the median was 15.00.


SGX:1J5's Price-to-Owner-Earnings is ranked better than
84.59% of 266 companies
in the Healthcare Providers & Services industry
Industry Median: 20.705 vs SGX:1J5: 6.15

As of today (2024-05-22), Hyphens Pharma International's share price is S$0.295. Hyphens Pharma International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was S$0.03. Therefore, Hyphens Pharma International's PE Ratio for today is 10.17.

As of today (2024-05-22), Hyphens Pharma International's share price is S$0.295. Hyphens Pharma International's EPS without NRI for the trailing twelve months (TTM) ended in was S$0.03. Therefore, Hyphens Pharma International's PE Ratio without NRI for today is 10.17.

During the past 8 years, Hyphens Pharma International's highest PE Ratio without NRI was 24.78. The lowest was 6.97. And the median was 10.50.


Hyphens Pharma International Price-to-Owner-Earnings Historical Data

The historical data trend for Hyphens Pharma International's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International Price-to-Owner-Earnings Chart

Hyphens Pharma International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial - 7.50 29.09 20.00 6.98

Hyphens Pharma International Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 20.00 - 6.98 -

Competitive Comparison of Hyphens Pharma International's Price-to-Owner-Earnings

For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hyphens Pharma International's Price-to-Owner-Earnings Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's Price-to-Owner-Earnings falls into.



Hyphens Pharma International Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Hyphens Pharma International's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.295/0.05
=5.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hyphens Pharma International  (SGX:1J5) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Hyphens Pharma International Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyphens Pharma International (SGX:1J5) Business Description

Traded in Other Exchanges
N/A
Address
16 Tai Seng Street, Level 4, Singapore, SGP, 534138
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines